[Germany's Novartis Chief proposes "More competition through decentralized contracts"].
Kosche
Dirk
D
Färber
Lothar
L
D035843:Biomedical Research; D002986:Clinical Trials as Topic; D032982:Contracts; D017046:Cost Savings; D003362:Cost-Benefit Analysis; D004338:Drug Combinations; D004345:Drug Industry / Q000191:economics*; D004358:Drug Therapy / Q000191:economics*; D005858:Germany; D006801:Humans; D007189:Indans / Q000627:therapeutic use; D004364:Pharmaceutical Preparations / Q000191:economics*; D015363:Quinolones / Q000627:therapeutic use
D004338:Drug Combinations; D007189:Indans; D004364:Pharmaceutical Preparations; D015363:Quinolones; C510790:indacaterol